Abstract
Introduction
The object of the current communication is to discuss the theory and the evidence for the use of l-carnitine in calcium channel blocker and metformin poisonings.
Case Report
A 68-year-old male known for hypertension and type II diabetes was admitted to the critical care unit of a community hospital following an overdose of amlodipine and metformin. The patient was intubated, ventilated, and hemodynamically supported with vasopressors. Despite calcium, glucagon, high-dose insulin (HDI), and lipid emulsion for calcium channel blocker and bicarbonate for metabolic acidosis, the patient remained hemodynamically unstable. The patient was considered too unstable to initiate continuous renal replacement therapy; and without access to extracorporeal life support, the administration of l-carnitine was administered as a last resort. One hour after l-carnitine, the norepinephrine requirements started to decrease, the patient began to improve and was subsequently extubated successfully without apparent sequelae in less than 4 days.
Discussion
l-Carnitine combined with HDI may have helped with the calcium channel blocker (CCB) poisoning by decreasing insulin resistance, promoting intracellular glucose transport, facilitating the metabolism of free fatty acids, and increasing calcium channel sensitivity. It may have also stimulated oxidative utilization of glucose instead of converting pyruvate into lactate and contributed to decrease lactate production with metformin poisoning.
This is a preview of subscription content, log in via an institution to check access.
References
Kline JA, Leonova E, Schroeder J, Williams T, Watts J (1996) Myocardial metabolism during graded intraportal verapamil infusion in awake dogs. J Cardiovasc Pharm 27:719–726
Perez E, Chu J, Bania T, Medljei K (2011) l-Carnitine increases survival in a murine model of severe verapamil toxicity. Acad Emerg Med 18:1135–1140
Gibault JP, Frey A, Guiraud M, Schirardin H, Bouletreau P, Bach AC (1988) Effects of l-carnitine infusion on intralipid clearance and utilization. Study carried out in septic patients of an intensive care unit. J Parenter Enter Nutr 12(1):29–34
Cederblad G (1984) Fat metabolism following an intravenous bolus dose of a fat emulsion and carnitine. Clin Physiol 4:159–168
Mingrone G, Greco AV, Capristo E, Benedetti G, Giancaterini A, DeGaetano A, Gasbarrini G (1999) l-Carnitine improves glucose disposal in type 2 diabetic patients. J Am Coll Nutr 18(1):77–82
Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS (2011) High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol 49:277–283
Spedding M, Mir AK (1987) Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand. Br J Pharmacol 92(2):457–468
Holger JS, Engebretsen KM, Stellpflug SJ, Cole JB, Cooper AC, Harris CR (2010) A consecutive case series (abstract). Clin Toxicol 48:613
Du X, Edelstein D, Obici S, Higham N, Zou MH, Brownlee M (2006) Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Investig 116(4):1071–1080
Nguyen HL, Concepcion L (2011) Metformin intoxication requiring dialysis. Hemodial Int 15:S68–S71
Acknowledgments
We would like to thank Dr Chris Chan for reviewing the manuscript and our patient for giving his consent to this publication.
Conflict of Interest
The authors have no conflict of interest or financial disclosure. This case has never been presented at a meeting or never been submitted as an abstract.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
St-Onge, M., Ajmo, I., Poirier, D. et al. l-Carnitine for the Treatment of a Calcium Channel Blocker and Metformin Poisoning. J. Med. Toxicol. 9, 266–269 (2013). https://doi.org/10.1007/s13181-013-0301-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-013-0301-3